Veran nears $5M fundraising goal for airway imaging
Summary
Missouri-based Veran Medical Technologies is on the verge of closing a $5 million funding round in support of its electromagnetic airway mapping system, regulatory filings show. So far 16 unnamed investors have participated in funding, the same number listed in a January update when the company notched nearly $3 million raised in the round. Veran is developing its SPiNDrive 2.0 airway mapping system, which uses the natural structure of the lungs to reach deep regions and target otherwise inaccessible lesions. The SPiNDrive system won FDA clearance in 2010 and Veran named GE Healthcare its exclusive distributor in 2011. The SPiNDrive device hopes to provide a means to earlier detect signs of lung cancer by using electromagnetic navigation to allow physicians to biopsy solitary pulmonary nodules that are hard to reach by traditional means, according to its website.
Classifications
AskAI Classifications
LabelsLinked Companies
